Covered recipient · General Payments record
MARITZA K WILSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2024
$3,728.04
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $455.99 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $252.78 | 9 |
| Insulet Corporation | $63.96 | 2 |
| Astellas Pharma US Inc | $47.03 | 2 |
| Phadia US Inc. | $28.13 | 1 |
| Lilly USA, LLC | $26.11 | 1 |
| Abbott Laboratories | $20.28 | 1 |
| ViiV Healthcare Company | $17.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $20.28 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125219454 | CMS |
| Astellas Pharma US Inc | $29.75 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139358039 | CMS |
| Astellas Pharma US Inc | $17.28 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139274296 | CMS |
| Insulet Corporation | $34.54 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116799894 | CMS |
| Insulet Corporation | $29.42 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116799892 | CMS |
| Lilly USA, LLC | $26.11 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135113798 | CMS |
| Novo Nordisk Inc | $20.66 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096893183 | CMS |
| Novo Nordisk Inc | $21.07 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096920348 | CMS |
| Novo Nordisk Inc | $123.91 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097711346 | CMS |
| Novo Nordisk Inc | $9.75 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097590808 | CMS |
| Novo Nordisk Inc | $18.63 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097060946 | CMS |
| Novo Nordisk Inc | $15.09 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097218059 | CMS |
| Novo Nordisk Inc | $15.12 | 06/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096628976 | CMS |
| Novo Nordisk Inc | $5.20 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096862862 | CMS |
| Novo Nordisk Inc | $23.35 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096710102 | CMS |
| Phadia US Inc. | $28.13 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067583002 | CMS |
| ViiV Healthcare Company | $17.70 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112805179 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.